Obese diabetes patients gain A1C benefit from bypass liner

10/1/2013 | Medscape (free registration)

A small study presented at the European Association for the Study of Diabetes meeting revealed severely obese type 2 diabetes patients who used EndoBarrier, a duodenal-jejunal bypass liner, showed reduced A1C levels, dropping from 8.5% to 7.5% at one year. In addition, patients reduced their body weight by an average of 10% and experienced improvements in fasting glucose levels and systolic blood pressure.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC